REMAP-CAP Trial

All Done!

A bit more to do?    Log in


The latest from the Spiral blog . . .

The medical world has really stepped up in terms of collaboration during this pandemic, because we can work faster when we work together

2020-11-24

The Result: Arthritis drug found effective in treating sickest COVID-19 intensive care patients.

November 2020.

Read more ยป

Spiral Team 2020



 
 

Follow us on Twitter

     
 

Like us on Facebook




 

REMAP-CAP

REMAP-CAP is a Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia. The primary aim of the study is to identify the effect of a range of interventions to improve all-cause mortality at 90 days.

About the software

Spinnaker is a tailored, web based, software and database solution for managing your multi-centre clinical study including the recording of patient data, recording and alerting of events, inventory management and reporting on data collected during the course of your study. Spinnaker is user friendly, adaptable and can be delivered quickly. You can read more on the Spinnaker website or contact Audrey on spinnaker@spiral.co.nz.

 

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.

This instance of REMAP-CAP hosted on our MAGPIE server